PODD: Insulet Corporation Stocks News on August 27, 2025

Insulet Gains 77.2% in a Year: What's Driving the Rally?

PODD

Zacks

4 days ago

Insulet Gains 77.2% in a Year: What's Driving the Rally?

Edwards Lifesciences Stock Pumps Up Its Relative Strength Rating

PODD

Investor's Business Daily

5 days ago

Edwards Lifesciences Stock Pumps Up Its Relative Strength Rating

PODD

MT Newswires

6 days ago

Barclays Adjusts Price Target on Insulet to $300 From $266, Maintains Equalweight Rating

Omnipod Maker Hit A Buy Point. Here's Where To Pick Up Shares.

PODD

Investor's Business Daily

6 days ago

Omnipod Maker Hit A Buy Point. Here's Where To Pick Up Shares.

Dow Jones Futures: Palantir, Oracle, Other Growth Leaders Keep Falling; What To Do Now

PODD

Investor's Business Daily

7 days ago

Dow Jones Futures: Palantir, Oracle, Other Growth Leaders Keep Falling; What To Do Now

Insulet Stock Breaks Out — Again — As Momentum Continues

PODD

Investor's Business Daily

7 days ago

Insulet Stock Breaks Out — Again — As Momentum Continues

Insulet to Participate in Upcoming Investor Conferences

PODD

Business Wire

8 days ago

Insulet to Participate in Upcoming Investor Conferences

Diabetes stocks rally after RFK comments on HHS campaign

PODD

TipRanks

2 months ago

Diabetes stocks rally after RFK comments on HHS campaign

PODD

Argus Research

2 months ago

PODD: Raising target price to $326.00

How Is Insulet's Stock Performance Compared to Other Medical Devices Stocks?

PODD

Barchart

2 months ago

How Is Insulet's Stock Performance Compared to Other Medical Devices Stocks?

Insulet to Share Additional Evidence Demonstrating the Impact of Omnipod® 5 on Improved Health Outcomes at the American Diabetes Association 85th Scientific Sessions

PODD

Business Wire

2 months ago

Insulet to Share Additional Evidence Demonstrating the Impact of Omnipod® 5 on Improved Health Outcomes at the American Diabetes Association 85th Scientific Sessions

Cisco upgraded, CoreWeave downgraded: Wall Street’s top analyst calls

PODD

TipRanks

2 months ago

Cisco upgraded, CoreWeave downgraded: Wall Street’s top analyst calls

PODD

Investing.com

2 months ago

Truist starts on diabetes device makers, sees glucose monitor, insulin pump growth

PODD

MT Newswires

2 months ago

Truist Initiates Insulet at Buy With $365 Price Target

1 Cash-Producing Stock with Exciting Potential and 2 to Steer Clear Of

PODD

StockStory

2 months ago

1 Cash-Producing Stock with Exciting Potential and 2 to Steer Clear Of

PODD

Simply Wall St.

2 months ago

Insulet (NasdaqGS:PODD) Launches Omnipod 5 iPhone App With Dexcom G7 Compatibility

PODD

Zacks

2 months ago

Here's Why You Should Retain PODD Stock in Your Portfolio Now

PODD

Argus Research

3 months ago

PODD: Rating decreased to a HOLD

Insulet’s Omnipod® 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users

PODD

Business Wire

3 months ago

Insulet’s Omnipod® 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users

PODD

StockStory

3 months ago

PODD Q1 Earnings Call: Insulet Highlights New Leadership and Strong Omnipod Adoption

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

PODD

Zacks

3 months ago

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

PODD

StockStory

3 months ago

3 Reasons Investors Love Insulet (PODD)

PODD

StockStory

3 months ago

Q1 Patient Monitoring Earnings: Insulet (NASDAQ:PODD) Earns Top Marks

PODD

Zacks

3 months ago

Here's Why Insulet (PODD) is a Strong Growth Stock

PODD

MT Newswires

3 months ago

TD Cowen Adjusts Price Target on Insulet to $379 From $324

S&P 500 Wraps Up Best May Since 1990: 5 Top Stocks in the ETF

PODD

Zacks

3 months ago

S&P 500 Wraps Up Best May Since 1990: 5 Top Stocks in the ETF

Reflecting On Patient Monitoring Stocks’ Q1 Earnings: Masimo (NASDAQ:MASI)

PODD

StockStory

3 months ago

Reflecting On Patient Monitoring Stocks’ Q1 Earnings: Masimo (NASDAQ:MASI)

PODD

Investor's Business Daily

3 months ago

Solventum Stock Earns RS Rating Upgrade

1 Surging Stock with Exciting Potential and 2 to Question

PODD

StockStory

3 months ago

1 Surging Stock with Exciting Potential and 2 to Question

PODD

Investing.com

3 months ago

Goldman Sachs initiates coverage of medtech stocks Insulet and Dexcom at Buy

PODD

MT Newswires

3 months ago

Goldman Sachs Initiates Insulet at Buy With $380 Price Target

PODD

Simply Wall St.

3 months ago

Is Insulet Corporation (NASDAQ:PODD) A High Quality Stock To Own?

PODD

MT Newswires

3 months ago

Raymond James Adjusts Price Target on Insulet to $360 From $328, Maintains Outperform Rating

Insulet Gains 78.5% in a Year: What's Driving the Stock?

PODD

Zacks

3 months ago

Insulet Gains 78.5% in a Year: What's Driving the Stock?

Insulet to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025

PODD

Business Wire

3 months ago

Insulet to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025

PODD

Zacks

3 months ago

Zacks Industry Outlook Highlights Insulet, MacroGenics, Cellectar Biosciences and Allurion Technologies

PODD

MT Newswires

3 months ago

Citigroup Adjusts Price Target on Insulet to $380 From $320, Maintains Buy Rating

4 Medical Product Stocks to Watch From a Challenging Industry

PODD

Zacks

3 months ago

4 Medical Product Stocks to Watch From a Challenging Industry

PODD

Zacks

3 months ago

Why Insulet (PODD) is a Top Growth Stock for the Long-Term

PODD

MT Newswires

3 months ago

Bernstein Adjusts Insulet Price Target to $375 From $355

Patient Monitoring Stocks Q1 Teardown: ResMed (NYSE:RMD) Vs The Rest

PODD

StockStory

3 months ago

Patient Monitoring Stocks Q1 Teardown: ResMed (NYSE:RMD) Vs The Rest

PODD

MT Newswires

3 months ago

Insulet Insider Sold Shares Worth $960,320, According to a Recent SEC Filing

PODD

Insider Monkey

3 months ago

Insulet Corporation (PODD): Among the Stocks Analysts Are Upgrading Today

PODD

FX Empire

3 months ago

Outlier Money Flows Lift Insulet

1 Mid-Cap Stock to Target This Week and 2 to Avoid

PODD

StockStory

3 months ago

1 Mid-Cap Stock to Target This Week and 2 to Avoid

PODD

Argus Research

3 months ago

PODD: Raising target price to $346.00

PODD

MT Newswires

3 months ago

Morgan Stanley Adjusts Price Target on Insulet to $355 From $325, Maintains Overweight Rating

Insulet Announces Publication of 2024 Sustainability Report

PODD

Business Wire

3 months ago

Insulet Announces Publication of 2024 Sustainability Report

PODD

MT Newswires

3 months ago

Wolfe Research Upgrades Insulet to Outperform From Peer Perform, Price Target is $350

Insulet Q1 Earnings Top Estimates, Stock Up, 2025 Sales View Raised

PODD

Zacks

3 months ago

Insulet Q1 Earnings Top Estimates, Stock Up, 2025 Sales View Raised

PODD

MT Newswires

3 months ago

Redburn Atlantic Adjusts Price Target on Insulet to $350 From $315, Maintains Buy Rating

S&P 500 Giants Visa, Insulet Lead 5 Stocks Near Buy Points

PODD

Investor's Business Daily

4 months ago

S&P 500 Giants Visa, Insulet Lead 5 Stocks Near Buy Points

PODD

Morningstar Research

4 months ago

Analyst Report: Insulet Corporation

S&P 500 Gains & Losses Today: Index Pulls Back Early Climb Amid Anticipation of Trade Talks

PODD

Investopedia

4 months ago

S&P 500 Gains & Losses Today: Index Pulls Back Early Climb Amid Anticipation of Trade Talks

Insulet Stock Soars To A High After Robust Earnings; This Customer Management Name Pops

PODD

Investor's Business Daily

4 months ago

Insulet Stock Soars To A High After Robust Earnings; This Customer Management Name Pops

PODD

StockStory

4 months ago

Why Insulet (PODD) Stock Is Trading Up Today

Insulet Stock Soars to Lead S&P 500 Gainers Friday

PODD

Investopedia

4 months ago

Insulet Stock Soars to Lead S&P 500 Gainers Friday

Insulet Q1 beat, Sweetgreen sinks on outlook, Wolfspeed drops

PODD

Yahoo Finance Video

4 months ago

Insulet Q1 beat, Sweetgreen sinks on outlook, Wolfspeed drops

PODD

Simply Wall St.

4 months ago

Insulet (NasdaqGS:PODD) Announces $125M Buyback, Raises Revenue Guidance For 2025

Top Stock Movers Now: Tesla, Monster Beverage, Insulet, and More

PODD

Investopedia

4 months ago

Top Stock Movers Now: Tesla, Monster Beverage, Insulet, and More

PODD

MT Newswires

4 months ago

RBC Raises Price Target on Insulet to $330 From $325, Keeps Outperform Rating

PODD

Thomson Reuters StreetEvents

4 months ago

Q1 2025 Insulet Corp Earnings Call

Dow Jones Futures Rise As Trump Says 80% China Tariff 'Seems Right'; Robinhood Leads 6 New Buys

PODD

Investor's Business Daily

4 months ago

Dow Jones Futures Rise As Trump Says 80% China Tariff 'Seems Right'; Robinhood Leads 6 New Buys

PODD

MT Newswires

4 months ago

Canaccord Genuity Lifts Price Target on Insulet to $331 From $324, Maintains Buy Rating

PODD

MT Newswires

4 months ago

Oppenheimer Adjusts Price Target on Insulet to $324 From $312, Maintains Outperform Rating

PODD

MT Newswires

4 months ago

Baird Adjusts Price Target on Insulet to $350 From $325, Maintains Outperform Rating

PODD

MT Newswires

4 months ago

Wells Fargo Adjusts Price Target on Insulet to $330 From $322, Maintains Overweight Rating

PODD

MT Newswires

4 months ago

Bernstein Adjusts Price Target on Insulet to $355 From $335, Maintains Outperform Rating

PODD

StockStory

4 months ago

What To Expect From Insulet’s (PODD) Q1 Earnings

PODD

Argus Research

4 months ago

PODD: Raising target price to $285.00

PODD

Zacks

4 months ago

Curious about Insulet (PODD) Q1 Performance? Explore Wall Street Estimates for Key Metrics

1 Growth Stock with Impressive Fundamentals and 2 to Think Twice About

PODD

StockStory

4 months ago

1 Growth Stock with Impressive Fundamentals and 2 to Think Twice About

PODD

MT Newswires

4 months ago

Insulet Shares Fall After Wolfe Research Downgrade

PODD

MT Newswires

4 months ago

Wolfe Research Downgrades Insulet to Peer Perform From Outperform

Insulet Names New CEO, Expects to Top Revenue Projections

PODD

Investopedia

4 months ago

Insulet Names New CEO, Expects to Top Revenue Projections

PODD

MedTech Dive

4 months ago

Ashley McEvoy named Insulet CEO

1 Healthcare Stock Worth Your Attention and 2 to Turn Down

PODD

StockStory

4 months ago

1 Healthcare Stock Worth Your Attention and 2 to Turn Down

PODD

MT Newswires

4 months ago

Insulate Names Ashley McEvoy Chief Executive

Insulet Appoints Ashley McEvoy President and CEO

PODD

Business Wire

4 months ago

Insulet Appoints Ashley McEvoy President and CEO

PODD

Simply Wall St.

4 months ago

Insulet (NASDAQ:PODD) Might Have The Makings Of A Multi-Bagger

PODD

Argus Research

4 months ago

PODD: Raising target price to $297.00

4 Medical Product Stocks to Buy From a Challenging Industry

PODD

Zacks

4 months ago

4 Medical Product Stocks to Buy From a Challenging Industry

PODD

Argus Research

4 months ago

PODD: Raising target price to $282.00

PODD

MT Newswires

4 months ago

RBC Cuts Price Target on Insulet to $325 From $340, Keeps Outperform Rating

BD, Teleflex, Insulet, UFP Technologies, and Haemonetics Shares Are Falling, What You Need To Know

PODD

StockStory

5 months ago

BD, Teleflex, Insulet, UFP Technologies, and Haemonetics Shares Are Falling, What You Need To Know

PODD

Zacks

5 months ago

Strength Seen in Insulet (PODD): Can Its 7.2% Jump Turn into More Strength?

5 High-Flying Large-Cap Stocks to Buy Amid Tariff-Led Market Rout

PODD

Zacks

5 months ago

5 High-Flying Large-Cap Stocks to Buy Amid Tariff-Led Market Rout

PODD

Argus Research

5 months ago

PODD: Lowering target price to $272.00

PODD

Zacks

5 months ago

PODD Stock Benefits From the Launch of Omnipod 5 in Canada

Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)

PODD

StockStory

5 months ago

Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)

This Insulin Pump Maker Expands Into New Territory And Its Stock Shows Relative Strength

PODD

Investor's Business Daily

5 months ago

This Insulin Pump Maker Expands Into New Territory And Its Stock Shows Relative Strength

PODD

Simply Wall St.

5 months ago

Insulet (NasdaqGS:PODD) Launches Omnipod 5 In Canada As Shares Dip 7%

PODD

MT Newswires

5 months ago

Citigroup Adjusts Insulet Price Target to $315 From $355, Maintains Buy Rating

Insulet Launches Omnipod® 5 Automated Insulin Delivery System in Canada, a Revolutionary New Technology for People Living with Type 1 Diabetes Ages Two Years and Above

PODD

CNW Group

5 months ago

Insulet Launches Omnipod® 5 Automated Insulin Delivery System in Canada, a Revolutionary New Technology for People Living with Type 1 Diabetes Ages Two Years and Above

PODD

Morningstar Research

5 months ago

Analyst Report: Insulet Corporation

Insulet to Announce First Quarter 2025 Financial Results on May 8, 2025

PODD

Business Wire

5 months ago

Insulet to Announce First Quarter 2025 Financial Results on May 8, 2025

Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks

PODD

StockStory

5 months ago

Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks

PODD

Argus Research

5 months ago

PODD: Lowering target price to $290.00

PODD

StockStory

5 months ago

3 Reasons Investors Love Insulet (PODD)

PODD

MT Newswires

5 months ago

Latest Insulet Corporation (PODD) News on August 27, 2025

Share on Social Networks: